Advances and challenges in deep generative models for de novo molecule generation
暂无分享,去创建一个
Qi Liu | Jing Yu | Guohui Chuai | Sheng Qu | Dongyu Xue | Yukang Gong | Zhao-Yi Yang | Ai-Zong Shen | Guohui Chuai | Dongyu Xue | Sheng Qu | Yukang Gong | Qi Liu | Jing Yu | Ai-Zong Shen | Zhao-Yi Yang
[1] Kilian Q. Weinberger,et al. An empirical study on evaluation metrics of generative adversarial networks , 2018, ArXiv.
[2] Thomas Blaschke,et al. Molecular de-novo design through deep reinforcement learning , 2017, Journal of Cheminformatics.
[3] Gisbert Schneider,et al. Deep Learning in Drug Discovery , 2016, Molecular informatics.
[4] Xiaohua Zhai,et al. The GAN Landscape: Losses, Architectures, Regularization, and Normalization , 2018, ArXiv.
[5] Andrew W. Moore,et al. Reinforcement Learning: A Survey , 1996, J. Artif. Intell. Res..
[6] Sebastian Nowozin,et al. Adversarial Variational Bayes: Unifying Variational Autoencoders and Generative Adversarial Networks , 2017, ICML.
[7] Alán Aspuru-Guzik,et al. Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models , 2017, ArXiv.
[8] Tom White,et al. Generative Adversarial Networks: An Overview , 2017, IEEE Signal Processing Magazine.
[9] Petra Schneider,et al. Generative Recurrent Networks for De Novo Drug Design , 2017, Molecular informatics.
[10] Vijay S. Pande,et al. Molecular graph convolutions: moving beyond fingerprints , 2016, Journal of Computer-Aided Molecular Design.
[11] Mario Lucic,et al. Are GANs Created Equal? A Large-Scale Study , 2017, NeurIPS.
[12] Lu Zhang,et al. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. , 2017, Drug discovery today.
[13] Alán Aspuru-Guzik,et al. Reinforced Adversarial Neural Computer for de Novo Molecular Design , 2018, J. Chem. Inf. Model..
[14] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 2. Enumerating Molecules from Their Extended Valence Sequences , 2003, J. Chem. Inf. Comput. Sci..
[15] Mostapha Benhenda,et al. ChemGAN challenge for drug discovery: can AI reproduce natural chemical diversity? , 2017, ArXiv.
[16] Vijay S. Pande,et al. MoleculeNet: a benchmark for molecular machine learning , 2017, Chemical science.
[17] Nicola De Cao,et al. MolGAN: An implicit generative model for small molecular graphs , 2018, ArXiv.
[18] Mostapha Benhenda. Can AI reproduce observed chemical diversity? , 2018, bioRxiv.
[19] Max Welling,et al. Auto-Encoding Variational Bayes , 2013, ICLR.
[20] Gisbert Schneider,et al. De Novo Design of Bioactive Small Molecules by Artificial Intelligence , 2018, Molecular informatics.
[21] Sergio Gomez Colmenarejo,et al. Hybrid computing using a neural network with dynamic external memory , 2016, Nature.
[22] Yibo Li,et al. Multi-objective de novo drug design with conditional graph generative model , 2018, Journal of Cheminformatics.
[23] Sergey Nikolenko,et al. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico. , 2017, Molecular pharmaceutics.
[24] Ruslan Salakhutdinov,et al. Learning Deep Generative Models , 2009 .
[25] Thomas Blaschke,et al. The rise of deep learning in drug discovery. , 2018, Drug discovery today.
[26] Alán Aspuru-Guzik,et al. Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules , 2016, ACS central science.
[27] Ole Winther,et al. Deep Generative Models for Molecular Science , 2018, Molecular informatics.
[28] Steven Skiena,et al. Syntax-Directed Variational Autoencoder for Molecule Generation , 2017 .
[29] Koji Tsuda,et al. ChemTS: an efficient python library for de novo molecular generation , 2017, Science and technology of advanced materials.
[30] Nathan Brown,et al. Exploiting QSAR methods in lead optimization. , 2006, Current opinion in drug discovery & development.
[31] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[32] Hiromasa Kaneko,et al. Inverse QSPR/QSAR Analysis for Chemical Structure Generation (from y to x) , 2016, J. Chem. Inf. Model..
[33] Thierry Kogej,et al. Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks , 2017, ACS central science.
[34] Forbes J. Burkowski,et al. A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem , 2009, J. Cheminformatics.
[35] Jin Woo Kim,et al. Molecular generative model based on conditional variational autoencoder for de novo molecular design , 2018, Journal of Cheminformatics.
[36] Andrey Kazennov,et al. The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology , 2016, Oncotarget.
[37] Thomas Blaschke,et al. Application of Generative Autoencoder in De Novo Molecular Design , 2017, Molecular informatics.
[38] Shakir Mohamed,et al. Variational Approaches for Auto-Encoding Generative Adversarial Networks , 2017, ArXiv.
[39] Lukás Burget,et al. Recurrent neural network based language model , 2010, INTERSPEECH.
[40] Evgeny Putin,et al. Adversarial Threshold Neural Computer for Molecular de Novo Design. , 2018, Molecular pharmaceutics.
[41] Sepp Hochreiter,et al. Fréchet ChemblNet Distance: A metric for generative models for molecules , 2018, ArXiv.
[42] Yoshua Bengio,et al. Generative Adversarial Networks , 2014, ArXiv.
[43] Gisbert Schneider,et al. Generative Models for Artificially‐intelligent Molecular Design , 2018, Molecular informatics.